Pape, U.-F.; Kasper, S.; Meiler, J.; Sinn, M.; Vogel, A.; Müller, L.; Burkhard, O.; Caca, K.; Heeg, S.; Büchner-Steudel, P.;
et al. Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study. Cancers 2020, 12, 3149.
https://doi.org/10.3390/cancers12113149
AMA Style
Pape U-F, Kasper S, Meiler J, Sinn M, Vogel A, Müller L, Burkhard O, Caca K, Heeg S, Büchner-Steudel P,
et al. Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study. Cancers. 2020; 12(11):3149.
https://doi.org/10.3390/cancers12113149
Chicago/Turabian Style
Pape, Ulrich-Frank, Stefan Kasper, Johannes Meiler, Marianne Sinn, Arndt Vogel, Lothar Müller, Oswald Burkhard, Karel Caca, Steffen Heeg, Petra Büchner-Steudel,
and et al. 2020. "Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study" Cancers 12, no. 11: 3149.
https://doi.org/10.3390/cancers12113149
APA Style
Pape, U. -F., Kasper, S., Meiler, J., Sinn, M., Vogel, A., Müller, L., Burkhard, O., Caca, K., Heeg, S., Büchner-Steudel, P., Rodriguez-Laval, V., Kühl, A. A., Arsenic, R., Jansen, H., Treasure, P., & Utku, N.
(2020). Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study. Cancers, 12(11), 3149.
https://doi.org/10.3390/cancers12113149
